TOP1 and colorectal carcinoma: Mucinous CRC has also been reported to respond poorly to 5-FU based treatment as a result of overexpression of DNA topoisomerase 1, microsatellite instability and abundant extracellular mucin which create a physical barrier that reduce chemotherapeutic efficacy [56, 57].